|
Market Closed -
Other stock markets
|
Pre-market 16:33:56 | |||
| 69.98 USD | -0.23% |
|
72.52 | +3.62% |
| 06-23 | Deutsche Bank Initiates Coverage on DexCom With Buy Rating, $86 Price Target | MT |
| 06-17 | AI Can Play 'Significant' Role in Tech for Managing Diabetes, Says David Roman | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Patient Monitoring Equipment | 2.45B | 2.91B | 3.62B | 4.03B | 4.66B | |||||
Total Assets | 4.86B | 5.39B | 6.26B | 6.48B | 6.34B | |||||
Interest Expense | -100M | -18.6M | - | -19M | -18.3M | |||||
Income Tax Expense | 19.2M | 49.6M | 169M | 133M | 252M | |||||
CAPEX | -389M | -365M | -237M | -359M | -364M | |||||
EBT | 174M | 391M | 710M | 709M | 1.09B | |||||
Gross Profit | 1.68B | 1.88B | 2.29B | 2.44B | 2.8B | |||||
D&A | 102M | 156M | 186M | 234M | 268M | |||||
Operating Income | 266M | 391M | 598M | 600M | 912M | |||||
Net Income | 155M | 341M | 542M | 576M | 836M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States (U.S.) | 1.85B | 2.14B | 2.63B | 2.89B | 3.33B | |||||
Total Assets | 4.86B | 5.39B | 544M | 465M | 406M | |||||
International | 599M | 768M | 997M | 1.14B | 1.33B | |||||
Total Assets | - | - | 515M | 632M | 684M | |||||
Total Assets | - | - | 125M | 306M | 108M | |||||
Total Assets | - | - | - | - | 439M |
- Stock Market
- Stocks
- DXCM Stock
- Financials DexCom, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
